Data / Form D filings / NEWLINK GENETICS CORP
NEWLINK GENETICS CORP: Form D filings
NEWLINK GENETICS CORP, a biotechnology company in Ames, IA, filed 8 Form D notices with the SEC between 2009 and 2011. The latest, on September 22, 2011, reports $12.8 million sold of a $12.8 million offering to 38 investors.
Find out what NEWLINK GENETICS CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2503 SOUTH LOOP DRIVE, SUITE 5100, Ames, IA, 50010
- Phone
- (515) 296-5555
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1126234
The full lists. Form D filings in Iowa: 206 rows, $10.30, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 22, 2011 | Amendment | $12,760,000 | $12,760,000 | $0 | 38 | Dec 1, 2010 | sec.gov |
| Aug 17, 2011 | Amendment | $10,360,687 | $10,360,687 | $0 | 40 | Jan 7, 2011 | sec.gov |
| Jun 3, 2011 | New notice | $250,000 | $250,000 | $0 | 1 | Sep 3, 2010 | sec.gov |
| Jan 31, 2011 | Amendment | $8,634,500 | $8,634,500 | $0 | 40 | Jan 7, 2011 | sec.gov |
| Jan 21, 2011 | New notice | $10,360,687 | $10,360,687 | $0 | 40 | Jan 7, 2011 | sec.gov |
| Dec 7, 2010 | New notice | $7,319,375 | $7,319,375 | $0 | 34 | Dec 1, 2010 | sec.gov |
| Jul 28, 2009 | New notice | $7,500,000 | $7,500,000 | $0 | 1 | Jul 17, 2009 | sec.gov |
| Jul 28, 2009 | Amendment | $30,000,000 | $20,714,105 | $9,285,895 | 114 | Feb 8, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ernest H. Talarico, III | Director | |
| Joseph J. Saluri | Director | |
| Nicholas Vahanian, M.D. | Executive Officer | |
| Kenneth J. Lynn | Executive Officer | |
| Gordon H. Link | Executive Officer | |
| David J. Lundquist | Director | |
| Sarah J. Alexander, M.D. | Director | |
| Tom H. Raffin, M.D. | Director | |
| Paul R. Edick | Director | |
| Charles Link, M.D. | Executive Officer, Director |
Every Form D from the week of Sep 19, 2011 · All recent filings in Iowa · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NEWLINK GENETICS CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.